dactinomycin has been researched along with Chromosomal Fragility in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dill, FJ; Jacky, PB | 1 |
| Buttin, G; Coquelle, A; Debatisse, M; Pipiras, E; Toledo, F | 1 |
| Bailey, AD; Weiner, AM; Yu, A | 1 |
3 other study(ies) available for dactinomycin and Chromosomal Fragility
| Article | Year |
|---|---|
Fragile X chromosome and chromosome condensation.
Topics: Aged; Bisbenzimidazole; Chromosome Fragile Sites; Chromosome Fragility; Dactinomycin; Ethidium; Female; Humans; Lymphocytes; Male; Netropsin; Olivomycins; X Chromosome | 1983 |
Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons.
Topics: Adenosine Deaminase; AMP Deaminase; Animals; Cell Line; Chromosome Fragile Sites; Chromosome Fragility; Coformycin; Cricetinae; Cricetulus; Dactinomycin; DNA Damage; Doxorubicin; Drug Resistance, Multiple; Enzyme Inhibitors; Gene Amplification; Genes, MDR; Methotrexate; Mutagens; Tetrahydrofolate Dehydrogenase; Vinblastine | 1997 |
Metaphase fragility of the human RNU1 and RNU2 loci is induced by actinomycin D through a p53-dependent pathway.
Topics: Chromosome Fragility; Dactinomycin; Genes, p53; Humans; In Situ Hybridization, Fluorescence; Metaphase; Nucleic Acid Synthesis Inhibitors; RNA, Small Nuclear; Tumor Cells, Cultured | 1998 |